UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes and industries were welcomed by CEO Dr. Lars Kober and CFO Sylwia Naamane. The visitors were very interested in UGA´s biologics and biosimilar pipeline in order to seek for cooperation opportunities.
After Dr. Lars Kober talked to the delegates about UGA´s services which includes cell line development, First CHOice® Medium platform and ready-to-use biosimilar cell lines, the audience were guided through well equipped laboratories to inspect state of the art instruments and techniques for the development of high producing NBE and biosimilar expressing cell lines. The leader of the delegation, Chairman Prof. Pu Cunhai, was impressed of UGA´s portfolio and expertise and thanked all involved team members of UGA Biopharma and Dr. Lars Kober for the cordial welcome.
UGA Biopharma GmbH
Phone: +49(0)3302 / 2024900